| Janet Marie Pelerossi, NP | |
|
1493 Cambridge St, Cambridge, MA 02139-1099 | |
| (617) 665-1267 | |
| Not Available |
| Full Name | Janet Marie Pelerossi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487051413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 53093 (Massachusetts) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | RN2324995 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janet Marie Pelerossi, NP 16 Delaney Dr, Walpole, MA 02081-5003 Ph: (781) 690-6766 | Janet Marie Pelerossi, NP 1493 Cambridge St, Cambridge, MA 02139-1099 Ph: (617) 665-1267 |
News Archive
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company intends to make a Substantial Issuer Bid (the "offer"), pursuant to which the Company will offer to repurchase for cancellation up to between 40% and 46% of its outstanding Common Shares for an aggregate purchase price of up to US$450 million.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
Patients with venous thromboembolism carry a high risk of recurrence. Accordingly, a 16-year Danish prospective cohort study of nearly 74,000 patients with incident VTE concluded that the risk of recurrence is substantial.
Two Canadian researchers will be keeping a close eye on what hundreds of thousands of soccer fans take to the World Cup in South Africa _ and what they potentially bring home.
Scientists at the Quadram Institute and the University of East Anglia have developed a new, rapid way of diagnosing bacterial lower respiratory tract infections in hours rather than days, that could improve patient care and slow the spread of antimicrobial resistance.
› Verified 2 days ago